FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302762960> ?p ?o ?g. }

• W4302762960 endingPage "221" @default.
• W4302762960 startingPage "210" @default.
• W4302762960 abstract "Anti-thymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy)-based regimens are widely used for graft-versus-host disease (GVHD) prophylaxis in haploidentical haematopoietic stem cell transplantation (haplo-HSCT). To improve the effectiveness of GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation (haplo-PBSCT), we conducted a multicentre, randomized clinical trial to determine the efficacy of reduced-dose PTCy (40 mg/kg/d on days 3 and 4) combined with low-dose post-transplant ATG (2.5 mg/kg on day 8)-based GVHD prophylaxis (reduced-dose PTCy/ATG) with fludarabine-busulfan-cytarabine (FBA) conditioning for patients with haematological malignancies. From 2018 to 2022, 122 patients from four institutions were randomly assigned 1:1 to either a reduced-dose PTCy/ATG or a standard-dose ATG group ('Beijing Protocol', ATG: 10 mg/kg). All patients achieved myeloid engraftment. Cumulative incidences of grade II-IV (11.5% vs 39.3%, p = 0.001) and grade III-IV (6.6% vs 24.6%, p = 0.014) acute GVHD at day 100 were significantly reduced in the reduced-dose PTCy/ATG group. Furthermore, two-year overall survival, disease-free survival and GVHD-free/relapse-free survival were significantly improved in the reduced-dose PTCy/ATG group (75.4% vs 54.1%, p = 0.021; 72.7% vs 55.0%, p = 0.044; 61.3% vs 42.3%, p = 0.022 respectively). Our results demonstrate that the addition of low-dose ATG to reduced-dose PTCy with FBA conditioning is a promising strategy in haplo-PBSCT." @default.
• W4302762960 created "2022-10-07" @default.
• W4302762960 creator A5003087746 @default.
• W4302762960 creator A5014237777 @default.
• W4302762960 creator A5014270790 @default.
• W4302762960 creator A5029797051 @default.
• W4302762960 creator A5037678826 @default.
• W4302762960 creator A5045196612 @default.
• W4302762960 creator A5049236401 @default.
• W4302762960 creator A5052917034 @default.
• W4302762960 creator A5066419540 @default.
• W4302762960 creator A5072453373 @default.
• W4302762960 creator A5090241332 @default.
• W4302762960 creator A5091366322 @default.
• W4302762960 date "2022-10-06" @default.
• W4302762960 modified "2023-10-18" @default.
• W4302762960 title "Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine–busulfan–cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial" @default.
• W4302762960 cites W1478343394 @default.
• W4302762960 cites W1584309797 @default.
• W4302762960 cites W2002547051 @default.
• W4302762960 cites W2008513538 @default.
• W4302762960 cites W2033205664 @default.
• W4302762960 cites W2039334806 @default.
• W4302762960 cites W2052971191 @default.
• W4302762960 cites W2060578002 @default.
• W4302762960 cites W2060741445 @default.
• W4302762960 cites W2062437906 @default.
• W4302762960 cites W2064085613 @default.
• W4302762960 cites W2079023050 @default.
• W4302762960 cites W2079110478 @default.
• W4302762960 cites W2086693026 @default.
• W4302762960 cites W2219528388 @default.
• W4302762960 cites W2379365975 @default.
• W4302762960 cites W2681369214 @default.
• W4302762960 cites W2712157351 @default.
• W4302762960 cites W2788411229 @default.
• W4302762960 cites W2789496953 @default.
• W4302762960 cites W2884698784 @default.
• W4302762960 cites W2886922441 @default.
• W4302762960 cites W2900494917 @default.
• W4302762960 cites W2913756819 @default.
• W4302762960 cites W2923738051 @default.
• W4302762960 cites W2954513875 @default.
• W4302762960 cites W2967234874 @default.
• W4302762960 cites W2972226667 @default.
• W4302762960 cites W2978299062 @default.
• W4302762960 cites W2982446134 @default.
• W4302762960 cites W3004720827 @default.
• W4302762960 cites W3016873190 @default.
• W4302762960 cites W3021230218 @default.
• W4302762960 cites W3081996634 @default.
• W4302762960 cites W3088847132 @default.
• W4302762960 cites W3129197373 @default.
• W4302762960 cites W3138767028 @default.
• W4302762960 doi "https://doi.org/10.1111/bjh.18483" @default.
• W4302762960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36200642" @default.
• W4302762960 hasPublicationYear "2022" @default.
• W4302762960 type Work @default.
• W4302762960 citedByCount "5" @default.
• W4302762960 countsByYear W43027629602022 @default.
• W4302762960 countsByYear W43027629602023 @default.
• W4302762960 crossrefType "journal-article" @default.
• W4302762960 hasAuthorship W4302762960A5003087746 @default.
• W4302762960 hasAuthorship W4302762960A5014237777 @default.
• W4302762960 hasAuthorship W4302762960A5014270790 @default.
• W4302762960 hasAuthorship W4302762960A5029797051 @default.
• W4302762960 hasAuthorship W4302762960A5037678826 @default.
• W4302762960 hasAuthorship W4302762960A5045196612 @default.
• W4302762960 hasAuthorship W4302762960A5049236401 @default.
• W4302762960 hasAuthorship W4302762960A5052917034 @default.
• W4302762960 hasAuthorship W4302762960A5066419540 @default.
• W4302762960 hasAuthorship W4302762960A5072453373 @default.
• W4302762960 hasAuthorship W4302762960A5090241332 @default.
• W4302762960 hasAuthorship W4302762960A5091366322 @default.
• W4302762960 hasConcept C126322002 @default.
• W4302762960 hasConcept C203014093 @default.
• W4302762960 hasConcept C2776694085 @default.
• W4302762960 hasConcept C2776755627 @default.
• W4302762960 hasConcept C2777408962 @default.
• W4302762960 hasConcept C2778041864 @default.
• W4302762960 hasConcept C2779263901 @default.
• W4302762960 hasConcept C2779972918 @default.
• W4302762960 hasConcept C2780611847 @default.
• W4302762960 hasConcept C2780882860 @default.
• W4302762960 hasConcept C2911091166 @default.
• W4302762960 hasConcept C71924100 @default.
• W4302762960 hasConcept C88879693 @default.
• W4302762960 hasConcept C90924648 @default.
• W4302762960 hasConceptScore W4302762960C126322002 @default.
• W4302762960 hasConceptScore W4302762960C203014093 @default.
• W4302762960 hasConceptScore W4302762960C2776694085 @default.
• W4302762960 hasConceptScore W4302762960C2776755627 @default.
• W4302762960 hasConceptScore W4302762960C2777408962 @default.
• W4302762960 hasConceptScore W4302762960C2778041864 @default.
• W4302762960 hasConceptScore W4302762960C2779263901 @default.
• W4302762960 hasConceptScore W4302762960C2779972918 @default.
• W4302762960 hasConceptScore W4302762960C2780611847 @default.
• W4302762960 hasConceptScore W4302762960C2780882860 @default.

• next